Disc raises $225.5m as it eyes approval of rare skin disorder drug
Disc Medicine has raised $225.5m through an upsized public offering to support the company’s pipeline, including its lead investigational drug,…
Disc Medicine has raised $225.5m through an upsized public offering to support the company’s pipeline, including its lead investigational drug,…